OWIM
APLS

Old West Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

Old West Investment Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-128,192
Closed -$2.8M – 63
2025
Q1 		$2.8M Buy
128,192
+14,569
+13% +$402K 1.01% 32
2024
Q4 		$3.63M Buy
113,623
+11,220
+11% +$337K 1.47% 22
2024
Q3 		$2.95M Buy
+102,403
New +$3.79M 1.14% 25

Other funds holding APLS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Old West Investment Management's APLS Position: Q2 2025 in Review

Old West Investment Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2025, closing a stake of 128,192 shares — an estimated $2.8M sold.

Old West Investment Management first reported a position in APLS in Q3 2024 and held it in 3 quarters. The position peaked at $3.63M in Q4 2024. 247 funds tracked by Wall St. Rank hold APLS as of Q2 2025.

  • Old West Investment Management reported no remaining Apellis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Old West Investment Management sold 128,192 Apellis Pharmaceuticals shares in Q2 2025, an estimated $2.8M.
  • Old West Investment Management first reported a position in Apellis Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • Old West Investment Management's Apellis Pharmaceuticals position peaked at $3.63M in Q4 2024.
  • 247 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2025.

Based on Old West Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.